Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
27 Leser
Artikel bewerten:
(0)

The Zacks Analyst Blog Highlights: Facebook, Tesla Motors, Amazon.com, Netflix and Alexion Pharmaceuticals

CHICAGO, April 8, 2014 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Facebook, Inc. (Nasdaq:FB-Free Report), Tesla Motors, Inc. (Nasdaq:TSLA-Free Report), Amazon.com Inc. (Nasdaq:AMZN-Free Report), Netflix, Inc. (Nasdaq:NFLX-Free Report) and Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report).

Zacks Investment Research, Inc., www.zacks.com.

Today, Zacks is promoting its 'Buy' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Monday's Analyst Blog:

Momentum Slide to Continue for Netflix, Facebook?

It was rough sailing for stocks on Friday with all major indices taking losses. The Dow lost 0.96% while the S&P 500 shed 1.25% by the end of the trading day. But the biggest sufferer was the Nasdaq, which closed the day 2.6% lower.

Internet, Biotech Stocks Take a Hit

This is the tech-heavy index's highest daily percentage loss since February. The decline comes right after Thursday's loss of 1%. The index is now 5% lower than its highest close this year, a milestone achieved on March 5.

More importantly, it was a cruel day for momentum stocks. Facebook, Inc. (Nasdaq:FB-Free Report) and electric car maker Tesla Motors, Inc. (Nasdaq:TSLA-Free Report) plunged 4.6% and 5.9%, respectively.

Meanwhile, Amazon.com Inc. (Nasdaq:AMZN-Free Report) and Netflix, Inc. (Nasdaq:NFLX-Free Report) also plummeted. The stocks lost 3.2% and 4.9%, respectively.

March's Trend Continues

This is a trend which has been continuing over the last month. Several big names have lost more than 20% during that period. The Street defines a drop of more than 20% or greater as a bear market and it seems that these stocks have descended into one which is their very own.

For instance, Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report) is 23% lower than its intraday high achieved on February 25. Meanwhile, Facebook has plummeted from the intra-day record achieved less than a month ago, losing 22% over the period. Yet the social media giant has still gained 3.8% this year, while Alexion is up 7% over the same period.

Are They Grossly Overvalued?

When using traditional valuation metrics, most of the momentum stocks seem grossly overvalued. The forward price-to-earnings ratios (P/E) for Amazon for the current financial year (F1) is 184.75. Netflix has a relatively modest P/E (F1) of 80.25. Tesla stands in between the two at 162.

Several momentum stocks fare no better when using other valuation metrics. Facebook has a P/E (F1) of 56.53, while its price to sales ratio is 17.76. The S&P 500 has an overall price to sales ratio of 1.7, which probably makes the social networking giant the most expensive stock on the index.

Investors Grow Wary

The high valuation of these stocks seems to be the primary reason for investors growing wary of them. The fact that most of them are priced well above the market average are keeping away potential buyers, probably rightly so. Momentum stocks grow on bullish expectations and this seems to be in short supply.

Further, there remains a possibility that when these stocks do rally, investors will sell. This is in order to make up for the losses suffered in the interim since those holding these stocks may feel at this point that they were picked up at the wrong time.

Today, Zacks is promoting its 'Buy' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on FB - FREE

Get the full Report on TSLA - FREE

Get the full Report on AMZN - FREE

Get the full Report on NFLX - FREE

Get the full Report on ALXN - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumedthat any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein andis subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO

SOURCE Zacks Investment Research, Inc.

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.